PK 11195 attenuates kainic acid‐induced seizures and alterations in peripheral‐type benzodiazepine receptor (PBR) protein components in the rat brain

This publication has 74 references indexed in Scilit:

• Orphenadrine prevents 3‐nitropropionic acid‐induced neurotoxicity in vitro and in vivo
  British Journal of Pharmacology, 2001
• Mitochondrial Creatine Kinase in Contact Sites: Interaction with Porin and Adenine Nucleotide Translocase, Role in Permeability Transition and Sensitivity to Oxidative Damage
  Neurosignals, 2001
• Peripheral-type benzodiazepine receptors: Their implication in brain disease
  Drug Development Research, 2000
• Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease
  Neuroscience Letters, 1998
• In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides
  Endocrinology, 1996
• Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients
  The Italian Journal of Neurological Sciences, 1996
• PK 11195 reduces the brain availability of lindane in rats and the convulsions induced by this neurotoxic agent
  Life Sciences, 1995
• Opposite effects of an agonist, R05-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice
  Life Sciences, 1984
• Kainic acid as a tool for the study of temporal lobe epilepsy
  Life Sciences, 1981
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976